Exelon Patch Market Size to Reach USD 193 Million by 2031 | Key Trends & Forecasts
lobal Exelon Patch market is witnessing accelerated clinical adoption as demand for effective, well-tolerated dementia therapies continues to rise. Valued at USD 117 million in 2024, the market is projected to reach USD 193 million by 2031, expanding at a strong CAGR of 7.7%. This momentum is driven by expanding diagnosis rates of Alzheimer’s and Parkinson’s disease dementia, growing preference for transdermal delivery, and improved caregiver training across healthcare systems.
Explore the detailed report https://www.24lifesciences.com/exelon-patch-market-8254
lobal Exelon Patch market is witnessing accelerated clinical adoption as demand for effective, well-tolerated dementia therapies continues to rise. Valued at USD 117 million in 2024, the market is projected to reach USD 193 million by 2031, expanding at a strong CAGR of 7.7%. This momentum is driven by expanding diagnosis rates of Alzheimer’s and Parkinson’s disease dementia, growing preference for transdermal delivery, and improved caregiver training across healthcare systems.
Explore the detailed report https://www.24lifesciences.com/exelon-patch-market-8254
Exelon Patch Market Size to Reach USD 193 Million by 2031 | Key Trends & Forecasts
lobal Exelon Patch market is witnessing accelerated clinical adoption as demand for effective, well-tolerated dementia therapies continues to rise. Valued at USD 117 million in 2024, the market is projected to reach USD 193 million by 2031, expanding at a strong CAGR of 7.7%. This momentum is driven by expanding diagnosis rates of Alzheimer’s and Parkinson’s disease dementia, growing preference for transdermal delivery, and improved caregiver training across healthcare systems.
Explore the detailed report https://www.24lifesciences.com/exelon-patch-market-8254